Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Revista Do Instituto De Medicina Tropical De Sao Paulo|July 1, 1993
[Sporotrichosis of the domestic cat (Felis catus): human transmission]S A Marques, S R Franco, R M de Camargo, et al.Hypertension (Dallas, Tex. : 1979)|February 8, 2012
Suboptimal inhibition of platelet cyclooxygenase-1 by aspirin in metabolic syndromeJames P Smith, Elias V Haddad, Mary B Taylor, et al.Revista Da Associacao Medica Brasileira (1992)|January 25, 2005
[Ketogenic diet for intractable epilepsy in children and adolescents: report of six cases]Marcio M Vasconcelos, Patricia M Couto Azevedo, Lívia Esteves, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2010
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapyB Besse, C Massard, V Haddad, et al.Arquivos De Neuro-Psiquiatria|September 21, 2005
[Pseudotumor cerebri secondary to dural sinus thrombosis: pediatric case report]Adriana Rocha Brito, Marcio M Vasconcelos, Romeu Cortes Domingues, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 22, 2007
Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patientsS Bonvalot, H Eldweny, V Haddad, et al.JACC. Heart Failure|April 16, 2018
Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic ShockMary E Keebler, Elias V Haddad, Chun W Choi, et al.Arquivos Brasileiros De Cardiologia|April 1, 1997
[Cardiac changes in children with AIDS]G V Haddad Herdy, M M Leite, V G Lopes, et al.Blood Cancer Journal|September 24, 2016
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemiaN Gökbuget, M Kelsh, V Chia, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2019
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trialD Moro-Sibilot, N Cozic, M Pérol, et al.Pageof 4